1. Home
  2. ARVN vs SSRM Comparison

ARVN vs SSRM Comparison

Compare ARVN & SSRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
  • SSRM
  • Stock Information
  • Founded
  • ARVN 2015
  • SSRM 1946
  • Country
  • ARVN United States
  • SSRM United States
  • Employees
  • ARVN N/A
  • SSRM N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • SSRM Precious Metals
  • Sector
  • ARVN Health Care
  • SSRM Industrials
  • Exchange
  • ARVN Nasdaq
  • SSRM Nasdaq
  • Market Cap
  • ARVN 1.8B
  • SSRM 1.5B
  • IPO Year
  • ARVN 2018
  • SSRM 1996
  • Fundamental
  • Price
  • ARVN $18.48
  • SSRM $6.95
  • Analyst Decision
  • ARVN Strong Buy
  • SSRM Hold
  • Analyst Count
  • ARVN 13
  • SSRM 3
  • Target Price
  • ARVN $63.00
  • SSRM $5.18
  • AVG Volume (30 Days)
  • ARVN 967.8K
  • SSRM 2.8M
  • Earning Date
  • ARVN 10-30-2024
  • SSRM 02-19-2025
  • Dividend Yield
  • ARVN N/A
  • SSRM N/A
  • EPS Growth
  • ARVN N/A
  • SSRM N/A
  • EPS
  • ARVN N/A
  • SSRM N/A
  • Revenue
  • ARVN $161,100,000.00
  • SSRM $1,098,328,000.00
  • Revenue This Year
  • ARVN $237.44
  • SSRM N/A
  • Revenue Next Year
  • ARVN N/A
  • SSRM $4.86
  • P/E Ratio
  • ARVN N/A
  • SSRM N/A
  • Revenue Growth
  • ARVN 1.07
  • SSRM N/A
  • 52 Week Low
  • ARVN $17.37
  • SSRM $3.76
  • 52 Week High
  • ARVN $53.08
  • SSRM $11.22
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 32.78
  • SSRM 59.14
  • Support Level
  • ARVN $17.37
  • SSRM $7.18
  • Resistance Level
  • ARVN $19.21
  • SSRM $8.33
  • Average True Range (ATR)
  • ARVN 1.64
  • SSRM 0.39
  • MACD
  • ARVN -0.59
  • SSRM 0.01
  • Stochastic Oscillator
  • ARVN 11.80
  • SSRM 54.46

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About SSRM SSR Mining Inc.

SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.

Share on Social Networks: